SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001144204-16-134652
Filing Date
2016-11-15
Accepted
2016-11-15 13:16:39
Documents
1
Period of Report
2016-09-30
Effectiveness Date
2016-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 12B-25 v453161_nt10q.htm NT 10-Q 28693
  Complete submission text file 0001144204-16-134652.txt   29849
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: NT 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 161998905
SIC: 2834 Pharmaceutical Preparations